Skip to main content
Fig. 4 | BMC Psychiatry

Fig. 4

From: Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study

Fig. 4

Mean PANSS Total Score From Double-Blind Baseline Through 6 Months of Open-Label Treatment With Lurasidone, by Treatment Assignment in the Double-Blind Study. LUR = lurasidone; PANSS = Positive and Negative Syndrome Scale; RIS = risperidone. *Subgroup entering open-label extension; 6-month completer analysis: LUR-LUR, n = 115; RIS-LUR, n = 71. †Patients in the RIS-LUR group received risperidone in the 12-month, double-blind study

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us